輸入代號或公司名稱後按 Enter
3164

景岳

0.00 (0.00%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
15.957成交張數19.94本益比1.05股價淨值比5.02%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q20.180.800.1615.0%1.20%5.43%
2026Q10.05-73.7%0.520.044.7%0.32%3.46%
2025Q40.281300.0%0.660.2524.6%1.90%4.26%
2025Q30.29314.3%0.400.2527.8%1.96%2.62%
2025Q2-0.10-158.8%0.18-0.09-7.8%-0.69%1.21%
2025Q10.19-52.5%0.450.1616.6%1.24%2.96%
2024Q40.020.660.022.3%0.15%4.29%
2024Q30.07-75.0%0.610.066.9%0.43%3.96%
2024Q20.17466.7%0.820.1515.6%1.10%5.43%
2024Q10.40300.0%0.680.3529.8%2.64%4.54%
2023Q4-0.03-118.8%0.38-0.02-2.7%-0.15%2.47%
2023Q30.28211.1%0.570.2431.3%1.83%3.65%
2023Q20.03-78.6%0.380.033.3%0.22%2.53%
2023Q10.10-63.0%0.490.0810.3%0.62%3.07%
2022Q40.16-68.6%0.660.1413.1%1.03%4.18%
2022Q30.09-66.7%1.010.0810.7%0.60%6.53%
2022Q20.14-22.2%1.190.1212.3%0.85%7.62%
2022Q10.27-22.9%1.230.2325.6%1.66%7.60%
2021Q40.51466.7%1.310.4437.1%3.27%8.36%
2021Q30.27-18.2%0.890.2422.4%1.75%5.82%
2021Q20.185.9%0.950.1514.8%1.09%6.19%
2021Q10.35250.0%0.940.3129.5%2.28%6.03%
2020Q40.090.690.088.8%0.58%4.49%
2020Q30.3383.3%0.560.2936.7%2.24%3.65%
2020Q20.17240.0%0.410.1519.3%1.13%2.68%
2020Q10.10-78.3%0.290.0911.1%0.64%1.72%
2019Q4-0.04-114.3%0.65-0.04-4.8%-0.28%4.00%
2019Q30.18-56.1%0.970.1617.8%1.14%6.02%
2019Q20.05-95.2%1.200.044.8%0.28%7.48%
2019Q10.46820.0%2.190.4145.2%2.71%13.52%
2018Q40.281.780.2526.1%1.67%11.18%
2018Q30.4157.7%1.320.3630.6%2.50%8.37%
2018Q21.04126.1%1.170.9395.5%6.69%7.54%
2018Q10.050.590.043.0%0.30%3.97%
2017Q4-0.180.51-0.16-13.7%-1.20%3.49%
2017Q30.26-1.750.2314.3%1.73%-11.01%
2017Q20.46-2.120.4128.6%3.16%-13.40%
2017Q1-0.03-2.59-0.02-1.9%-0.19%-16.63%
2016Q4-2.44-2.65-2.17-180.4%-15.70%
2016Q3-0.11-0.10-6.9%-0.68%